The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Interactions Between the Intestinal Microbiome and Liver Diseases
Open accessAbstract
The human intestine harbors a diverse community of microbes that promote metabolism and digestion in their symbiotic relationship with the host. Disturbance of its homeostasis can result in disease. We review factors that disrupt intestinal homeostasis and contribute to nonalcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, and cirrhosis. Liver disease has long been associated with qualitative and quantitative (overgrowth) dysbiotic changes in the intestinal microbiota. Extrinsic factors, such as the Western diet and alcohol, contribute to these changes. Dysbiosis results in intestinal inflammation, a breakdown of the intestinal barrier, and translocation of microbial products in animal models. However, the contribution of the intestinal microbiome to liver disease goes beyond simple translocation of bacterial products that promote hepatic injury and inflammation. Microbial metabolites produced in a dysbiotic intestinal environment and host factors are equally important in the pathogenesis of liver disease. We review how the combination of liver insult and disruptions in intestinal homeostasis contribute to liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the impact of changes to the composition and function of the microbiome in NASH include altered bile acid metabolism and loss of integrity of the gut-vascular barrier, precipitating leakage of LPS and bacteria into the liver via the portal circulation (14–16).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“Changes in gut microbiota (dysbiosis) may play a key role in the pathogenesis of NAFLD/NASH and cholestasis52–54 and may also impact on BA composition and signalling.51 55”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [54]
In the citing paper
“However, a failing gut barrier and alterations of the gut microbiota in chronic liver disease (CLD) contribute to chronic inflammation and the progression of liver diseases12, and thereby increase risk for the development of hepatocellular carcinoma (HCC) as the final stage of the disease process 13–15.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
In the citing paper
“Metagenomic studies have revealed substantial alterations in the composition of the gut microbiota in a range of CLD as well as in patients with cirrhosis12,32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Cited by
Sorted by citations
Items 601–700 of 974
Mulè, S., Galla, R., Parini, F., Botta, M., Ferrari, S., & Uberti, F. (2025) · Foods · doi:10.3390/foods14112003 · Cited by 11
Song, Y., Guo, W., Wang, J., Liu, S., Li, Z., & Li, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1334935 · Cited by 11
Qin, P., Li, Y., Su, Y., Wang, Z., Wu, R., Liang, X., Zeng, Y., Guo, P., Yu, Z., Huang, X., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05312-6 · Cited by 13
Su, J., Dai, Y., Wu, X., Zhou, X., Fang, X., Ge, X., & Zhao, L. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13624 · Cited by 12
Wang, T., Rong, X., & Zhao, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.936815 · Cited by 10
Zhang, L., Zhang, S., Zou, W., Hu, Y., Gao, Y., Zhang, J., & Zheng, J. (2024) · Clinical Science · doi:10.1042/cs20240997 · Cited by 11
Specific alterations in gut microbiota are associated with prognosis of Budd-Chiari syndrome
Sun, Y.-L., Li, W., Ding, P., Wang, Z.-W., Wei, C., Ma, X.-X., Zhang, R., Wu, Y., Zhou, L., Liang, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23234 · Cited by 11
[Gut microbiota-an important contributor to liver diseases].
Wang, F., Cui, Q., Zeng, Y., & Peng, C. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.04.23 · Cited by 11
Pyocyanin Modulates Gastrointestinal Transformation and Microbiota
Peng, W., Li, H., Zhao, X., Shao, B., & Zhu, K. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07726 · Cited by 14
Identifying Molecular Targets to Improve Immune Function in Alcoholic Hepatitis
Bataller, R. A., & Mandrekar, P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.013 · Cited by 11
Li, S., Chen, F., Zou, Y., Ning, L., Zhang, G., Zhang, S., & Yao, Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-4809 · Cited by 10
Al‐Busafi, S. A., Alwassief, A., Madian, A., Atalla, H., Alboraie, M. A. A., Elbahrawy, A., & Eslam, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.108730 · Cited by 10
Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma
Hussain, M. M., Bi, F., Wang, J., Zhai, A., Li, F., & Hu, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71330 · Cited by 11
Sausa, M., Fucarino, A., Paladino, L., Zummo, F. P., Fabbrizio, A., Felice, V. D., Rappa, F., Barone, R., Marino, A., & Macaluso, F. (2024) · Biomedicines · doi:10.3390/biomedicines12020382 · Cited by 11
Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function
Sun, Y., Wu, Y., Li, M.-R., Wei, Y.-Y., Guo, M. L., & Zhang, Z. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i43.4660 · Cited by 10
Microbiome and gut-liver interactions: From mechanisms to therapies
Anis, M. A., Shahid, Y., Majeed, A. A., & Abid, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i40.111409 · Cited by 12
Yang, Y., Xu, K., Chen, X., Ding, J., Shi, J., & Li, J. (2022) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2021-0168 · Cited by 10
Bitto, N., Ghigliazza, G., Lavorato, S., Caputo, C., & Mura, V. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030934 · Cited by 11
Moderate exercise-induced dynamics on key sepsis-associated signaling pathways in the liver
Osuru, H. P., Ikeda, K., Atluri, N., & Thiele, R. H. (2023) · Critical Care · doi:10.1186/s13054-023-04551-1 · Cited by 11
Pan, C., Li, H., Wang, F., Qin, J., Huang, Y., & Zhao, W. (2024) · Animals · doi:10.3390/ani14060927 · Cited by 10
Characteristics of Three Microbial Colonization States in the Duodenum of the Cirrhotic Patients
Zha, H., Chen, Y., Wu, J., Chang, K., Lu, Y., Zhang, H., Xie, J., Wang, Q., Tang, R., & Li, L. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0270 · Cited by 10
Ishizawa, S., Nishi, A., Kaifuchi, N., Shimobori, C., Nahata, M., Yamada, C., Iizuka, S., Ohbuchi, K., Nishiyama, M., Fujitsuka, N., et al. (2022) · Gene · doi:10.1016/j.gene.2022.146856 · Cited by 10
The gut-liver axis: impact of a mouse model of small-bowel bacterial overgrowth
Wang, Q., Wang, B., Saxena, V., Miles, L., Tiao, J., Mortensen, J. E., & Nathan, J. D. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.08.049 · Cited by 10
Ghosh, S., Ghosh, A. J., Islam, R., Sarkar, S., & Saha, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313548 · Cited by 9
Seok, J., & Suk, K. T. (2020) · Journal of Liver Cancer · doi:10.17998/jlc.20.1.32 · Cited by 9
Wu, I.-T., Yeh, W.-J., Huang, W., & Yang, H. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109583 · Cited by 9
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00009-0 · Cited by 8
Miao, Z., Lai, Y., Zhao, Y., Chen, L., Zhou, J., Li, C., & Lan, H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8811021 · Cited by 9
Yu, J., Shi, X., Ma, J., Chen, R., Dong, S., Lu, S., Wu, J., Yan, C., Wu, J., Zheng, S., et al. (2021) · Biomolecules · doi:10.3390/biom11081195 · Cited by 9
Zha, H., Fang, D., van der Reis, A. L., Chang, K., Yang, L.-Y., Xie, J., Shi, D., Xu, Q., Li, Y., & Li, L. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01827-2 · Cited by 9
Blesl, A., Jüngst, C., Lammert, F., Fauler, G., Rainer, F., Leber, B., Feldbacher, N., Stromberger, S., Wildburger, R., Spindelboeck, W., et al. (2020) · Nutrients · doi:10.3390/nu12092728 · Cited by 10
An Evaluation Method of Human Gut Microbial Homeostasis by Testing Specific Fecal Microbiota
Wu, Z., Pan, X., Yuan, Y., Lou, P., Gordejeva, L., Ni, S., Zhu, X., Liu, B., Wu, L., Li, L., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.03.007 · Cited by 8
Li, X., Liu, S., Xie, J., Liu, L., Duan, C., Yang, L., Wang, Y., Wu, Y., Shan, N., Zhang, Y., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17371 · Cited by 8
Peng, Q., Yang, K., Hou, Q., Zheng, H., Zheng, X., & Xie, G.-F. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105379 · Cited by 10
Makkar, S. K., & Bishnupuri, K. S. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1676796 · Cited by 10
Sarafian, M. H., Ding, N. S., Holmes, E. C., & Hart, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00028-8 · Cited by 9
Zhang, R., Lu, Z., Xu, Y., Peng, Q., Xiao, M., & Sang, S. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/5625222 · Cited by 9
Hepatoprotective properties of water kefir: A traditional fermented drink and its potential role
Adnyana, I., Aligita, W., Singgih, M., & Sutrisno, E. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_29_22 · Cited by 11
B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients
Vietsch, E. E., Latifi, D., Verheij, M., van der Oost, E., de Wilde, R. F., Haen, R., van den Boom, A. L., Koerkamp, B. G., Doornebosch, P. G., van Verschuer, V. M. T., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1230306 · Cited by 8
Wang, Z.-Y., Xie, W.-Q., Xiang, Z.-Y., Zhang, C.-Y., Xie, Y.-G., Quah, R. Y. C., & Ding, G.-H. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174428 · Cited by 8
Pathogenesis of NAFLD and NASH
Maher, J. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_4 · Cited by 8
von Wulffen, M. T., Clark, P. J., Macdonald, G. A., Raj, A. S., Kendall, B. J., Powell, E. E., Jones, M., & Holtmann, G. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13657 · Cited by 8
Wang, R., Jiang, C., Wu, Z., Wang, Z., Peng, Y., Li, Z., Zhang, Z., Lin, H., & Chen, Z. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.02.003 · Cited by 9
Microbiota and Alcoholic Liver Disease
Chen, P., Miyamoto, Y., Mazagova, M., Lee, K., Eckmann, L., & Schnabl, B. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13129 · Cited by 8
Self-citationTINIAKOS, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00005-3 · Cited by 7
Skladaný, Ľ., Kubánek, N., Selčanová, S. A., Žilinčanová, D., Havaj, D. J., Sulejova, K. K., Šoltýs, K., Messingerová, L., Lichvár, M., Lafférs, L., et al. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00381-5 · Cited by 7
Regulatory role of S1P and its receptors in sepsis-induced liver injury
Wang, B., Wu, X., Cheng, J., Ye, J., Zhu, H., & Liu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1489015 · Cited by 7
Interacting roles of gut microbiota and T cells in the development of autoimmune hepatitis
Wu, Q., Ge, Z., Lv, C., & He, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584001 · Cited by 7
Liú, Y., Geng, H., Han, B., Song, K., Li, J., Ji, S., Xue, J., & Zhang, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147096 · Cited by 7
Zhang, Q., Li, L. X., Lu, H., Meng, L., Zeng, Q., Wang, R., Wang, D., Tong, T., Liu, Y., & Yang, H. (2025) · Aquaculture Reports · doi:10.1016/j.aqrep.2025.103077 · Cited by 9
The Role of Oral and Gut Microbiota in Bone Health: Insights from Bacterial Extracellular Vesicles
Liang, P., Chen, X., Su, Z., Luo, Y., Wang, T., Jiang, L., Guo, L., & Luo, T. (2025) · Microorganisms · doi:10.3390/microorganisms13102254 · Cited by 10
Mykytenko, A. О., & Yeroshenko, G. А. (2020) · World of Medicine and Biology · doi:10.26724/2079-8334-2020-3-73-194-200 · Cited by 7
He, J., Yang, M., Quan, X., Wen, J., Yang, L., Yang, H., Zhao, G., Hou, Y., Lu, J., Xu, L., et al. (2023) · International Journal of Urology · doi:10.1111/iju.15158 · Cited by 7
Coles, M. E., Graham, B. D., Latorre, J. D., Petrone-García, V. M., Hernández-Velasco, X., Castellanos-Huerta, I., Sun, X., Hargis, B. M., El-Ashram, S. A., Shehata, A. A., et al. (2023) · Food and Nutrition Sciences · doi:10.4236/fns.2023.143016 · Cited by 9
Roles of Human Gut Microbiota in Liver Cirrhosis Risk: A Two-Sample Mendelian Randomization Study
Li, O., Han, X., Kim, D., Yang, F., & Bao, Z. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.11.011 · Cited by 9
Zhan, Y., Li, Q., Li, T., Yu, Q., Li, Y., Cheng, X., Sun, Y., Wang, X., Guo, F., Zhang, H., et al. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104613 · Cited by 7
García–Álvarez, M., Berenguer, J., Jiménez‐Sousa, M. Á., Vázquez‐Morón, S., Carrero, A., Gutiérrez‐Rivas, M., Aldámiz‐Echevarría, T., López, J. C., García‐Broncano, P., & Resino, S. (2015) · AIDS · doi:10.1097/qad.0000000000001007 · Cited by 7
Ramirez, M., Pell, N., Mejías, M., & Fernández, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11093-2_5 · Cited by 7
Minimal Hepatic Encephalopathy: Silent Tragedy
Shiha, G. E.-S., & Mousa, N. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88231 · Cited by 7
Nakamura, A., Yamamoto, K., Takeda, R., Yamada, R., Kubo, A., Morikawa, K., Ando, S., Shimazaki, T., Izumi, T., Umemura, M., et al. (2022) · Hepatology Research · doi:10.1111/hepr.13757 · Cited by 7
Nikiforova, Y. V., Fadieienko, G. D., Gridnev, A. E., Kushnir, I. Е., Solomentseva, Т. А., Chernova, V. M., & Kurinna, O. G. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202203108 · Cited by 7
Santopaolo, F., Coppola, G., Giuli, L., Gasbarrini, A., & Ponziani, F. R. (2022) · Microbiology Research · doi:10.3390/microbiolres13030038 · Cited by 8
Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions
Chen, E. B., Cason, C. A., Gilbert, J. A., & Ho, K. J. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3755-4 · Cited by 7
Argueta, P. P., Salazar, M. J., Attar, B. M., Simons-Linares, C. R., & Shen, B. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa224 · Cited by 7
Risk factors for the development of sepsis in patients with cirrhosis in intensive care units
Kou, Y., Yang, Y., Du, S., Liu, X., He, K., Yuan, W., & Nie, B. (2023) · Clinical and Translational Science · doi:10.1111/cts.13549 · Cited by 7
Mitochondria in Liver Diseases
Grattagliano, I., de Bari, O., Palo, D. D., Montecucco, F., Carbone, F., Oliveira, P. J., Wang, D. Q. ‐., & Portincasa, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_7 · Cited by 7
Functions of hepatic non-parenchymal cells in alcoholic liver disease
Choi, W., Kim, M., & Jeong, W. (2019) · Liver Research · doi:10.1016/j.livres.2019.04.002 · Cited by 7
Qian, W., Liu, Y., Li, X., & Pan, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4221 · Cited by 7
The intestinal microbiota and hepatocellular carcinoma
Effenberger, M., & Tilg, H. (2020) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-020-00597-x · Cited by 6
Schnabl, B. (2014) · PubMed Central · Cited by 7
Self-citationTorre, A., Cisneros-Garza, L. E., Castillo-Barradas, M., Navarro–Álvarez, N., Sandoval-Salas, R., González-Huezo, M. S., Pérez-Hernández, J. L., Méndez-Guerrero, O., Ruiz-Manríquez, J. A., Trejo-Estrada, R., et al. (2023) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101140 · Cited by 6
Lu, W., Aihaiti, A., Abudukeranmu, P., Liu, Y., & Gao, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05320-6 · Cited by 8
Dolapchiev, L. I., Gonzales, K. A., Graham, L. C., Gagea, M., Stevenson, H. L., Kwan, S., & Beretta, L. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s485532 · Cited by 6
Feng, Y., Mei, W., Chen, Q., Chen, X., Ni, Y., Lei, M., & Liu, J. (2025) · Microorganisms · doi:10.3390/microorganisms13010200 · Cited by 6
Hidalgo, V. S., Witney, A. A., Chico, M. E., Vaca, M. G., Arévalo‐Cortes, A., Schuyler, A. J., Platts‐Mills, T. A. E., Ster, I. C., & Cooper, P. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-89224-5 · Cited by 7
Zhang, B., Chen, X., He, C., Su, T., Cao, K., Li, X., Duan, J., Chen, M., Zhu, Z., & Yu, W. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1144786 · Cited by 6
Wen, Y., Zhang, T., Zhang, B., Wang, F., Wei, X., Wei, Y., Ma, X., & Tang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27819 · Cited by 6
Kurmaev, D. P., Bulgakova, S. V., Treneva, E. V., Pervyshin, N. A., Sharonova, L. A., & Dolgikh, Y. A. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-222-2-111-119 · Cited by 6
The gut‐immune‐liver axis in patients with alcohol use disorder and clinically low serum zinc levels
Thakurdesai, A., Jha, S. K., Erinkitola, I., Said, A., Joshi, T., Schwandt, M. L., Parajuli, D., Singal, A. K., Kong, M., Cave, M. C., et al. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15408 · Cited by 6
Chen, J., Song, Y. J., Zeng, W., Wang, L., Qin, J., Fang, L., & Ding, Y. (2024) · Shock · doi:10.1097/shk.0000000000002441 · Cited by 7
Majumdar, A., & Tsochatzis, E. A. (2016) · Europe PMC (PubMed Central) · Cited by 6
Intestinal Dysbiosis and Non-Alcoholic Fatty Liver Disease
Auguet, T., Bertran, L., & Binetti, J. (2021) · Biochemistry · doi:10.5772/intechopen.92972 · Cited by 7
Pregnancy-specific transcriptional changes upon endotoxin exposure in mice
Motomura, K., Romero, R. J., Tarca, A. L., Galaz, J., Bhatti, G., Done, B., Arenas‐Hernandez, M., Levenson, D., Slutsky, R., Hsu, C., et al. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0159 · Cited by 6
Pathogenic or Therapeutic: The Mediating Role of Gut Microbiota in Non-Communicable Diseases
Bu, F., Yao, X., Lü, Z., Yuan, X., Chen, C., Li, L., Li, Y., Jiang, F., Zhu, L., Shi, G., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.906349 · Cited by 6
Aljahdali, B. A., Bajaber, A. S., Al-Nouri, D. M., Alkhalifah, A., Arzoo, S., & Alasmari, A. A. (2023) · Life · doi:10.3390/life13061336 · Cited by 9
Wang, Y.-Y., Lin, H., Wang, K.-L., Que, G., Cao, T., Zhu, L.-M., Yang, X., & Yang, X. (2023) · Chinese Medical Sciences Journal · doi:10.24920/004220 · Cited by 7
Dietary Saturated Lipids in Alcoholic Liver Disease: New Microbiota-Targeting Bullets?
Tilg, H., & Gao, B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.11.023 · Cited by 6
The Microbiome and Metabolome in Alcoholic Liver Disease
Patel, K. G., & Pyrsopoulos, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00028-2 · Cited by 6
Gao, Y., Zhang, J., Xiao, X., Ren, Y., Yan, X., Yue, J., Wang, T., Wu, Z., Lv, Y., & Wu, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.640448 · Cited by 7
The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease
Jacob, J. S., Ahmed, A., & Cholankeril, G. T. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000759 · Cited by 6
Cuesta‐Sancho, S., Márquez-Coello, M., Illanes-Álvarez, F., Márquez-Ruiz, D., Arizcorreta, A., Galán‐Sánchez, F., Montiel, N., Rodríguez‐Iglesias, M., & González, J. A. G. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i1.62 · Cited by 6
Strnad, P., Güldiken, N., Helenius, T. O., Misiorek, J. O., Nyström, J. H., Lähdeniemi, I. A. K., Silvander, J. S. G., Kuscuoglu, D., & Toivola, D. M. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.08.004 · Cited by 6
Ivanova, I. (2016) · Scripta Scientifica Medica · doi:10.14748/ssm.v48i2.1481 · Cited by 6
Nonpharmacologic Management of Hepatic Encephalopathy
Weir, V. R., & Reddy, K. R. (2020) · Clinics in Liver Disease · doi:10.1016/j.cld.2020.01.003 · Cited by 7
Gut microbiota and hepatocellular carcinoma
Wang, P., & Chen, K. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.10.34 · Cited by 7
You, W., Ji, J., Wen, D., Wang, C., Sun, X., & Zhao, P. (2025) · npj gut and liver. · doi:10.1038/s44355-024-00015-7 · Cited by 5
Wang, Y., Mu, W., Guan, J., Ma, P., Li, Y., Zhang, Y., Zhu, W., Zhou, Y., Zou, Y., Zeng, T.-X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116374 · Cited by 5
Lu, J., Zuo, H., Feng, R., Chen, Y., Ye, M.-L., Xu, H. X., Hu, J.-C., Song, J., Zhao, Y., Wang, J., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108030 · Cited by 5
Fondevila, M. F., Kreimeyer, H., Hsu, C. L., Tamargo‐Azpilicueta, J., Day, L. Z., Gritsenko, M., Attah, K., Cabré, N., Harberts, A., Tonetti, F. R., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.01.013 · Cited by 5
Self-citationExpression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
Bertran, L., Adalid, L., Vilaró-Blay, M., Barrientos‐Riosalido, A., Aguilar, C., Martínez, S., Sabench, F., Castillo, D. D., Porras, J. A., Alibalic, A., et al. (2023) · Metabolites · doi:10.3390/metabo13040496 · Cited by 5
Metadata
- Authors
- Schnabl, B., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schnabl, Bernd
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1513-1524
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3996054
- OpenAlex
- W1975691929
- Cited by
- 971
- References
- 86
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 88 · 2023: 101 · 2022: 88 · 2021: 92 · 2020: 102 · 2019: 88 · 2018: 89 · 2017: 58 · 2016: 64 · 2015: 77 · 2014: 31
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (U01 AA021856, R01 AA020703, 2 P42 ES010337, K08 DK081830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- gut microbiota, gut-liver axis, non-alcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, liver cirrhosis, dysbiosis, intestinal homeostasis, intestinal barrier dysfunction, intestinal inflammation, microbial translocation, microbial metabolites, Western diet, alcohol
- MeSH terms
- Animals, Bacteria, Bile Acids and Salts, Fatty Liver, Humans, Intestines, Liver Cirrhosis, Liver Diseases, Liver Diseases, Alcoholic, Risk Factors, Host-Pathogen Interactions, Microbiota, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
